Imprinting disorder | Prevalence | OMIM | Chromosomes/imprinted regions | Type of mutation/epimutation and their frequencies | MLID | Mosaicism | Recurrence risk | Main clinical features | |
---|---|---|---|---|---|---|---|---|---|
Transient Neonatal Diabetes Mellitus (TNDM) | 1/300.000 | 601410 | 6q24: PLAGL1: alt-TSS | upd(6)pat | 40Â % | Â | Â | <1Â % | IUGR, transient diabetes, hyperglycemia without ketoacidosis, macroglossia, omphalocele |
paternal duplications | 40Â % | Â | No | Up to 50Â % | |||||
methylation defects | 20Â % | ~50Â % | Yes | <1Â % | |||||
Upd(6)mat | Unknown | Â | Chromosome 6, 6q16.1qter | upd(6)mat | Â | Â | Yes | Unknown | Â |
Silver-Russell syndrome (SRS; Russell-Silver Syndrome, RSS) | 1/75.000-1/100.000 | 180860 | 7 | upd(7)mat | ~10Â % | 1 casea | No | <1Â % | IUGR/PNGR, small prematurely calcified placenta, rel. macrocephaly at birth, hemihypotrophy, prominent forehead, triangular face, feeding difficulties |
11p15: | upd(11p15)mat | single case | Â | Unknown | Rare | ||||
 | Genome-wide uniparental diploidy | single case |  | Yes | Rare | ||||
 | maternal duplication | <1 % |  | No | Up to 50 % | ||||
H19/IGF2: IG DMR | hypomethylation | >38 %a | 7-10Â % | Yes | <1Â % | ||||
CDKN1C | point mutations | 1 family reported | Â | No | In familial cases: up to 50Â % in case of maternal transmission | ||||
IGF2 | point mutations | 1 family reported | Â | No | Â | ||||
Beckwith-Wiedemann syndrome (BWS; Wiedemann-Beckwith syndrome, EMG) | 1/15.000 | 130650 | 11p15: | upd(11p15)pat | ~20Â % | Â | Yes | <1Â % | Pre- and postnatal overgrowth, organomegaly, macroglossia, omphalocele, neonatal hypoglycemia, hemihypertrophy, increased tumour risk |
 | Genome-wide uniparental diploidy | ~2 % |  | Yes | <1 % | ||||
 | chromosomal aberrations | 2-4 % |  | No | Up to 50 % | ||||
IH19/IGF2: IG DMR; KCNQ1OT1: TSS-DMR | hypermethylation | 5-10Â % | Â | Yes | unclear | ||||
 | hypomethylation | 40-50 % | 25 % | Yes | <1 % | ||||
CDKN1C | point mutations | 5 % (sporadic) 40–50 % (families) |  | No | Up to 50 % | ||||
Kagami-Ogata syndrome (KOS14; upd(14)pat syndrome) | unknown | 608149 | 14q32: | upd(14)pat | 65Â % | Â | Â | in case of RT | IUGR, polyhydramnion, abdominal and thoracal wall defects, bell-shaped thorax, coat-hanger ribs |
MEG3/DLK1: IG DMR | maternal deletion | 15Â % | up to 50Â % | ||||||
MEG3: TSS DMR | aberrant methylation | 20Â % | <1Â % | ||||||
Temple syndrome (TS14; upd(14)mat syndrome) | unknown | 616222 | 14q32: | upd(14)mat | 78Â % | Â | Â | In case of RT | IUGR/PNGR, neonatal hypotonia, feeding difficulties in infancy, truncal obesity, scoliosis, precocious puberty, small feed and hands |
MEG3/DLK1: IG DMR | paternal deletion | 10Â % | Â | Up to 50Â % | |||||
MEG3: TSS DMR | aberrant methylation | 12Â % | 1 casea | <1Â % | |||||
Prader-Willi syndrome (PWS) | 1/25.000-1/10.000 | 176270 | 15q11-q13 | paternal deletion | 70Â % | Â | Â | Up to 50Â % | PNGR, mental retardation, neonatal hypotonia, hypogenitalism, hypopigmentation, obesity/hyperphagia |
upd(15)mat | <30Â % | Â | In case of RT | ||||||
aberrant methylation | ~1Â % | 1 case | <1Â % | ||||||
Angelman syndrome (AS) | 1/20.000-1/12.000 | 105830 | 15q11-q13: | maternal deletion | 70Â % | Â | No | Up to 50Â % | mental retardation, microcephaly, no speech, unmotivated laughing, ataxia, seizures, scoliosis |
 | upd(15)pat | 1-3 % |  |  | In case of RT | ||||
 | aberrant methylation | ~4 % |  | Yes | <1 % | ||||
UBE3A | point mutations | 10-15Â % | Â | No | In familial cases: up to 50Â % in case of maternal transmission | ||||
Precocious puberty (central precocious puberty 2; cppb2) | Unknown | 614356 | 15q11.2: MKRN3 | point mutations | 100Â % | Â | No | In familial cases: up to 50Â % in case of paternal transmission | Early activation of the hypothalamic-pituitary-gonadal axis results in gonadotropin-dependent precocious puberty |
Upd(16)mat | Unknown | Â | Chromosome 16 | upd(16)mat, often associated with chromosomal aberrations | Â | Â | Yes | <1Â % | IUGR (40-85Â %); heterogeneous, but no specific or unique symptoms |
Pseudohypo-parathyroidism (PHP1B, PHP1C, PHP1A) | unknown | 603233 | 20q13: | Maternally inherited deletions causing aberrant methylation | 8.5Â % | Â | Â | Up to 50Â % in case of maternal transmission | Resistance to PTH and other hormones; Albright hereditary osteodystrophy, subcutaneous ossifications, feeding behaviour anomalies, abnormal growth patterns |
612462 | GNAS | isolated epimutations | 42.5Â % | 12.5Â % | Â | <1Â % | |||
103580 | Â | upd(20)pat | 2.5Â % | 12.5Â % | Â | <1Â % | |||
maternal and paternal heterozygous loss of function mutations in GNAS coding sequence | 46.5Â % | Â | No | Up to 50Â % in case of maternal transmission | |||||
Upd(20)mat syndrome | unknown | Â | Chromosome 20 | upd(20)mat | Â | Â | No | <1Â % | IUGR, PNGR, feeding difficulties |